Livongo Health, a Mountain View-based Applied Health Signals company that empowers people with chronic conditions to live better and healthier lives, announced that it has appointed former Cerner president Zane Burke as the new Chief Executive Officer. Company Founder and current CEO, Glen Tullman, will remain in his role as Executive Chairman (he previously served as both Executive Chairman and CEO).
Zane Burke Background
Prior to joining Livongo, Burke spent five years as president of health IT powerhouse Cerner Corp. During his 22 years with Cerner, he held various senior executive roles in sales, strategy, finance, and operations. Mr. Burke holds an MBA and Bachelor of Science degree in accounting from Kansas State University.
“With six in ten people living with a chronic condition, the time is right for Livongo’s experiential, fresh approach to improving the quality of life and the health status of people who live with these conditions,” said Burke. “As CEO, my focus will be working with this incredible team to grow the company so that we can create better health and care experiences for our Members, and more appropriately manage the resources consumed in managing those conditions for anyone paying for that care.”
Dr. Jennifer Schneider’s Promotion to President
In addition to the appointment of a new CEO, Livongo announced Dr. Jennifer Schneider’s promotion to President where she will focus on Product, Data Science, Software Engineering, Marketing, and Clinical Operations. Schneider previously served as the Company’s Chief Medical Officer.
Schneider joined Livongo in 2015, having most recently served as Castlight’s Chief Medical Officer. At the time, it was considered a coupe to land such a highly regarded industry leader for the company. Over the last three years, she has built the company’s clinical and data science operations, now considered industry-leading, and has helped to drive results that demonstrate a substantial and sustained reduction in A1c and financial ROI for clients. Over the last 12 months, her responsibilities have expanded in line with the Company’s growth, particularly in the strategy realm as the Company has moved beyond diabetes to focus on the health of the whole person.
“I’m excited about the possibilities in front of us as the leader in Applied Health Signals,” said Schneider. “The marketplace is recognizing our differentiated offering, and we’re now serving more than 600 of the largest, most innovative self-insured employers in the U.S., the two largest pharmacy benefit managers and a growing number of payers and health services organizations. As we rapidly grow our business and build new capabilities, we are able to aggregate and interpret more data on more conditions, and deliver actionable, personalized and timely health signals to more and more people with chronic conditions empowering them get and stay healthy.”
